Literature DB >> 2660552

Two daily doses of sucralfate or cimetidine in the healing of gastric ulcer. A comparative randomized study.

A Hjortrup1, L B Svendsen, H Beck, J Hoffmann, M Schroeder.   

Abstract

A double-blind, randomized study compared the healing of gastric ulcer during a twice-daily regimen of 2 g sucralfate or 400 mg cimetidine. The patients received the tablets one-half hour before breakfast and one-half hour before bedtime. The study included 76 patients with endoscopically proven gastric ulcer. Patients with ulcers less than 3 cm from the pyloric ring and patients with ulcers less than 3 mm in diameter were excluded from the study. Sixty-four patients completed the study. Healing was endoscopically assessed at four-week intervals for 12 weeks. After four, eight, and 12 weeks, the healing rates for cimetidine were 55, 81, and 94 percent, respectively; the healing rates for sucralfate were 52, 79, and 91 percent, respectively. No statistically significant difference was found between the two regimens. At 12 weeks, the risk of overlooking a difference in favor of one of the two dosage regimens was less than 20 percent. The results suggest that 2 g sucralfate twice daily is as effective in the healing of gastric ulcer as 400 mg cimetidine twice daily.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660552     DOI: 10.1016/0002-9343(89)90170-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.

Authors:  F Di Mario; G Battaglia; G Leandro; G Grasso; F Vianello; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients.

Authors:  G Battaglia; F Di Mario; P Dotto; G Leandro; A Pilotto; M Ferrana; F Vianello; S Vigneri; C V Colonna; R Naccarato
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

3.  Evidence-based clinical practice guidelines for peptic ulcer disease 2015.

Authors:  Kiichi Satoh; Junji Yoshino; Taiji Akamatsu; Toshiyuki Itoh; Mototsugu Kato; Tomoari Kamada; Atsushi Takagi; Toshimi Chiba; Sachiyo Nomura; Yuji Mizokami; Kazunari Murakami; Choitsu Sakamoto; Hideyuki Hiraishi; Masao Ichinose; Naomi Uemura; Hidemi Goto; Takashi Joh; Hiroto Miwa; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-02-15       Impact factor: 7.527

Review 4.  Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.

Authors:  M Deakin; J G Williams
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  Do concomitant diseases and therapies affect the persistence of ulcer symptoms in the elderly?

Authors:  F Di Mario; G Leandro; G Battaglia; A Pilotto; P Del Santo; F Vianello; M Franceschi; M Ferrana; T Dal Bianco; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.